Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Emotional Distress in Cancer Patients During the First Wave of the COVID-19 Pandemic.
Toquero P, Blanco Fernández C, López Martí MP, Hernández Marín B, Vera Cea EB, Garrido García A, Méndez Carrascosa E, Bañón Torres D, Donnay Candil O, Ballesteros García AI, Sánchez-Torres JM, Costas Rojo P, Mondéjar R, Colomer R, Romero-Laorden N. Toquero P, et al. Among authors: mondejar r. Front Psychol. 2021 Nov 5;12:755965. doi: 10.3389/fpsyg.2021.755965. eCollection 2021. Front Psychol. 2021. PMID: 34803837 Free PMC article.
Predictors of unknown cancer in patients with ischemic stroke.
Quintas S, Rogado J, Gullón P, Pacheco-Barcia V, Dotor García-Soto J, Reig-Roselló G, Mondéjar R, Colomer R, Vivancos J. Quintas S, et al. Among authors: mondejar r. J Neurooncol. 2018 May;137(3):551-557. doi: 10.1007/s11060-017-2741-0. Epub 2018 Jan 8. J Neurooncol. 2018. PMID: 29313183
Immune-related adverse events predict the therapeutic efficacy of anti-PD-1 antibodies in cancer patients.
Rogado J, Sánchez-Torres JM, Romero-Laorden N, Ballesteros AI, Pacheco-Barcia V, Ramos-Leví A, Arranz R, Lorenzo A, Gullón P, Donnay O, Adrados M, Costas P, Aspa J, Alfranca A, Mondéjar R, Colomer R. Rogado J, et al. Among authors: mondejar r. Eur J Cancer. 2019 Mar;109:21-27. doi: 10.1016/j.ejca.2018.10.014. Epub 2019 Jan 22. Eur J Cancer. 2019. PMID: 30682533
Effect of excess weight and immune-related adverse events on the efficacy of cancer immunotherapy with anti-PD-1 antibodies.
Rogado J, Romero-Laorden N, Sanchez-Torres JM, Ramos-Levi AM, Pacheco-Barcia V, Ballesteros AI, Arranz R, Lorenzo A, Gullon P, Garrido A, Serra López-Matencio JM, Donnay O, Adrados M, Costas P, Aspa J, Alfranca A, Mondejar R, Colomer R. Rogado J, et al. Among authors: mondejar r. Oncoimmunology. 2020 Apr 16;9(1):1751548. doi: 10.1080/2162402X.2020.1751548. eCollection 2020. Oncoimmunology. 2020. PMID: 32363123 Free PMC article.
When should we order a next generation sequencing test in a patient with cancer?
Colomer R, Mondejar R, Romero-Laorden N, Alfranca A, Sanchez-Madrid F, Quintela-Fandino M. Colomer R, et al. Among authors: mondejar r. EClinicalMedicine. 2020 Jul 31;25:100487. doi: 10.1016/j.eclinm.2020.100487. eCollection 2020 Aug. EClinicalMedicine. 2020. PMID: 32775973 Free PMC article. Review.
Peripheral Blood Mononuclear Cells Predict Therapeutic Efficacy of Immunotherapy in NSCLC.
Rogado J, Pozo F, Troule K, Sánchez-Torres JM, Romero-Laorden N, Mondejar R, Donnay O, Ballesteros A, Pacheco-Barcia V, Aspa J, Al-Shahrour F, Alfranca A, Colomer R. Rogado J, et al. Among authors: mondejar r. Cancers (Basel). 2022 Jun 12;14(12):2898. doi: 10.3390/cancers14122898. Cancers (Basel). 2022. PMID: 35740564 Free PMC article.
Usefulness and real-world outcomes of next generation sequencing testing in patients with cancer: an observational study on the impact of selection based on clinical judgement.
Colomer R, Miranda J, Romero-Laorden N, Hornedo J, González-Cortijo L, Mouron S, Bueno MJ, Mondéjar R, Quintela-Fandino M. Colomer R, et al. Among authors: mondejar r. EClinicalMedicine. 2023 Jun 1;60:102029. doi: 10.1016/j.eclinm.2023.102029. eCollection 2023 Jun. EClinicalMedicine. 2023. PMID: 37304496 Free PMC article.
37 results